Share Price and Basic Stock Data
Last Updated: July 2, 2025, 8:09 pm
| PEG Ratio | 0.00 |
|---|
Competitors of Hindustan Agrigenetics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Nagarjuna Agri Tech Ltd | 69.7 Cr. | 74.4 | 83.3/17.6 | 7.19 | 0.00 % | 1.34 % | 1.34 % | 10.0 | |
| Hindustan Agrigenetics Ltd | 30.0 Cr. | 68.2 | 94.0/40.0 | 0.00 % | 2.46 % | 2.55 % | 10.0 | ||
| Elegant Floriculture & Agrotech (India) Ltd | 12.7 Cr. | 4.93 | 7.76/4.38 | 10.9 | 9.16 | 0.00 % | 5.85 % | 5.22 % | 10.0 |
| Industry Average | 0 Cr | 49.18 | 10.90 | 8.18 | 0.00% | 3.22% | 3.04% | 10.00 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 |
| Expenses | 0.01 | 0.12 | 0.33 | 0.05 | 0.11 | 0.12 | 0.03 | 0.07 | -0.06 | 0.01 | 0.01 | 0.00 | 0.24 |
| Operating Profit | 0.02 | -0.12 | -0.29 | -0.05 | -0.08 | -0.12 | 0.01 | -0.07 | 0.09 | -0.01 | 0.03 | 0.00 | -0.21 |
| OPM % | 66.67% | -725.00% | -266.67% | 25.00% | 300.00% | 75.00% | -700.00% | ||||||
| Other Income | 0.01 | 0.03 | 0.09 | 0.14 | 0.15 | 0.03 | 0.14 | 0.16 | 0.15 | 0.15 | 0.02 | 0.15 | 0.24 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.03 | -0.09 | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.08 | 0.23 | 0.13 | 0.04 | 0.14 | 0.02 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.02 | -0.09 | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.07 | 0.22 | 0.13 | 0.04 | 0.14 | 0.02 |
| EPS in Rs |
Last Updated: March 3, 2025, 11:59 pm
Below is a detailed analysis of the quarterly data for Hindustan Agrigenetics Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Expenses, as of Dec 2024, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Sep 2024) to 0.24 Cr., marking an increase of 0.24 Cr..
- For Operating Profit, as of Dec 2024, the value is -0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Sep 2024) to -0.21 Cr., marking a decrease of 0.21 Cr..
- For OPM %, as of Dec 2024, the value is -700.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Sep 2024) to -700.00%, marking a decrease of 700.00%.
- For Other Income, as of Dec 2024, the value is 0.24 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Sep 2024) to 0.24 Cr., marking an increase of 0.09 Cr..
- For Interest, as of Dec 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2024, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.01 Cr..
- For Profit before tax, as of Dec 2024, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Sep 2024) to 0.02 Cr., marking a decrease of 0.12 Cr..
- For Tax %, as of Dec 2024, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
- For Net Profit, as of Dec 2024, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Sep 2024) to 0.02 Cr., marking a decrease of 0.12 Cr..
- For EPS in Rs, as of Dec 2024, the value is 0.00. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 28, 2025, 4:11 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.19 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
| Expenses | 0.12 | 0.12 | 0.26 | 0.12 | 0.16 | 0.21 | 0.22 | 0.59 | 0.19 | 0.23 | 0.72 | 0.39 | 0.26 |
| Operating Profit | -0.07 | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.65 | -0.32 | -0.19 |
| OPM % | -140.00% | -100.00% | -333.33% | -100.00% | -166.67% | -320.00% | -266.67% | -210.53% | -216.67% | -283.33% | -928.57% | -457.14% | -271.43% |
| Other Income | -0.03 | 0.05 | 0.30 | 0.95 | 0.28 | 0.19 | 0.04 | 0.04 | -0.05 | 0.06 | 10.56 | 0.96 | 0.56 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 |
| Profit before tax | -0.12 | -0.03 | 0.09 | 0.88 | 0.17 | 0.02 | -0.13 | -0.37 | -0.18 | -0.11 | 9.91 | 0.60 | 0.33 |
| Tax % | -66.67% | 133.33% | 0.00% | 25.00% | 35.29% | 3,100.00% | -7.69% | -186.49% | -16.67% | -9.09% | 0.50% | 23.33% | |
| Net Profit | -0.04 | -0.07 | 0.09 | 0.66 | 0.11 | -0.59 | -0.12 | 0.33 | -0.15 | -0.10 | 9.86 | 0.47 | 0.33 |
| EPS in Rs | |||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -75.00% | 228.57% | 633.33% | -83.33% | -636.36% | 79.66% | 375.00% | -145.45% | 33.33% | 9960.00% | -95.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | 303.57% | 404.76% | -716.67% | -553.03% | 716.02% | 295.34% | -520.45% | 178.79% | 9926.67% | -10055.23% |
Hindustan Agrigenetics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -16% |
| 3 Years: | 10% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -166% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 50% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 28% |
| 3 Years: | 33% |
| Last Year: | -3% |
Last Updated: Unknown
No data available for the Balance Sheet data table.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -6,278.00 | -5,170.83 | -5,353.33 | -730.00 | -243.33 | -365.00 | -608.33 | 883.68 | -4,501.67 | -36,925.83 | -1,668.57 | 9,177.14 |
| ROCE % | 0.00% | -3.51% | -2.00% | 33.61% | 0.00% | 0.81% | -1.95% | -13.46% | -5.99% | -7.80% | -1.73% | 4.96% |
No valid data available for the Shareholding
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| Diluted EPS (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| Cash EPS (Rs.) | -0.61 | 1.15 | 22.41 | -0.21 | -0.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 27.32 | 27.65 | 26.58 | 4.17 | 4.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 27.32 | 28.02 | 26.95 | 4.55 | 4.77 |
| Revenue From Operations / Share (Rs.) | 0.17 | 2.35 | 24.43 | 0.28 | 0.13 |
| PBDIT / Share (Rs.) | -0.59 | 1.46 | 22.52 | -0.24 | -0.40 |
| PBIT / Share (Rs.) | -0.68 | 1.38 | 22.52 | -0.25 | -0.40 |
| PBT / Share (Rs.) | -0.69 | 1.38 | 22.52 | -0.25 | -0.40 |
| Net Profit / Share (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| PBDIT Margin (%) | -342.41 | 62.20 | 92.19 | -85.45 | -288.85 |
| PBIT Margin (%) | -388.97 | 58.64 | 92.17 | -87.40 | -295.28 |
| PBT Margin (%) | -399.09 | 58.64 | 92.17 | -87.40 | -295.28 |
| Net Profit Margin (%) | -395.59 | 45.44 | 91.71 | -76.62 | -238.42 |
| Return on Networth / Equity (%) | -2.53 | 3.85 | 84.29 | -5.28 | -7.52 |
| Return on Capital Employeed (%) | -2.42 | 4.91 | 83.54 | -5.53 | -8.59 |
| Return On Assets (%) | -2.45 | 3.68 | 79.74 | -1.18 | -4.94 |
| Asset Turnover Ratio (%) | 0.01 | 0.08 | 1.05 | 0.02 | 0.02 |
| Current Ratio (X) | 330.73 | 27.72 | 22.40 | 1.11 | 1.92 |
| Quick Ratio (X) | 330.73 | 27.72 | 22.40 | 1.11 | 1.92 |
| Interest Coverage Ratio (X) | -23.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | -26.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 24.41 | 13.01 | -8.02 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 316.56 | 12.59 | -0.74 | 0.00 | 0.00 |
| EV / EBITDA (X) | -92.45 | 20.24 | -0.80 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 383.23 | 21.77 | 0.20 | 0.00 | 0.00 |
| Price / BV (X) | 2.46 | 1.85 | 0.19 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 383.71 | 21.77 | 0.20 | 0.00 | 0.00 |
| EarningsYield | -0.01 | 0.02 | 4.44 | 0.00 | 0.00 |
After reviewing the key financial ratios for Hindustan Agrigenetics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.61. This value is below the healthy minimum of 3. It has decreased from 1.15 (Mar 24) to -0.61, marking a decrease of 1.76.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 27.32. It has decreased from 27.65 (Mar 24) to 27.32, marking a decrease of 0.33.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 27.32. It has decreased from 28.02 (Mar 24) to 27.32, marking a decrease of 0.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.17. It has decreased from 2.35 (Mar 24) to 0.17, marking a decrease of 2.18.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.59. This value is below the healthy minimum of 2. It has decreased from 1.46 (Mar 24) to -0.59, marking a decrease of 2.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 0. It has decreased from 1.38 (Mar 24) to -0.68, marking a decrease of 2.06.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 0. It has decreased from 1.38 (Mar 24) to -0.69, marking a decrease of 2.07.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 2. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For PBDIT Margin (%), as of Mar 25, the value is -342.41. This value is below the healthy minimum of 10. It has decreased from 62.20 (Mar 24) to -342.41, marking a decrease of 404.61.
- For PBIT Margin (%), as of Mar 25, the value is -388.97. This value is below the healthy minimum of 10. It has decreased from 58.64 (Mar 24) to -388.97, marking a decrease of 447.61.
- For PBT Margin (%), as of Mar 25, the value is -399.09. This value is below the healthy minimum of 10. It has decreased from 58.64 (Mar 24) to -399.09, marking a decrease of 457.73.
- For Net Profit Margin (%), as of Mar 25, the value is -395.59. This value is below the healthy minimum of 5. It has decreased from 45.44 (Mar 24) to -395.59, marking a decrease of 441.03.
- For Return on Networth / Equity (%), as of Mar 25, the value is -2.53. This value is below the healthy minimum of 15. It has decreased from 3.85 (Mar 24) to -2.53, marking a decrease of 6.38.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.42. This value is below the healthy minimum of 10. It has decreased from 4.91 (Mar 24) to -2.42, marking a decrease of 7.33.
- For Return On Assets (%), as of Mar 25, the value is -2.45. This value is below the healthy minimum of 5. It has decreased from 3.68 (Mar 24) to -2.45, marking a decrease of 6.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.08 (Mar 24) to 0.01, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 330.73. This value exceeds the healthy maximum of 3. It has increased from 27.72 (Mar 24) to 330.73, marking an increase of 303.01.
- For Quick Ratio (X), as of Mar 25, the value is 330.73. This value exceeds the healthy maximum of 2. It has increased from 27.72 (Mar 24) to 330.73, marking an increase of 303.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -23.78. This value is below the healthy minimum of 3. It has decreased from 0.00 (Mar 24) to -23.78, marking a decrease of 23.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -26.77. This value is below the healthy minimum of 3. It has decreased from 0.00 (Mar 24) to -26.77, marking a decrease of 26.77.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.41. It has increased from 13.01 (Mar 24) to 24.41, marking an increase of 11.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 316.56. This value exceeds the healthy maximum of 3. It has increased from 12.59 (Mar 24) to 316.56, marking an increase of 303.97.
- For EV / EBITDA (X), as of Mar 25, the value is -92.45. This value is below the healthy minimum of 5. It has decreased from 20.24 (Mar 24) to -92.45, marking a decrease of 112.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 383.23. This value exceeds the healthy maximum of 3. It has increased from 21.77 (Mar 24) to 383.23, marking an increase of 361.46.
- For Price / BV (X), as of Mar 25, the value is 2.46. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 2.46, marking an increase of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 383.71. This value exceeds the healthy maximum of 3. It has increased from 21.77 (Mar 24) to 383.71, marking an increase of 361.94.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to -0.01, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Agrigenetics Ltd:
- Net Profit Margin: -395.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.42% (Industry Average ROCE: 3.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -2.53% (Industry Average ROE: 3.04%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -26.77
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 330.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 10.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -395.59%
About the Company - Qualitative Analysis
Hindustan Agrigenetics Ltd. is a Public Limited Listed company incorporated on 25/07/1990 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L01119DL1990PLC040979 and registration number is 040979. Currently company belongs to the Industry of Floriculture. Company's Total Operating Revenue is Rs. 0.08 Cr. and Equity Capital is Rs. 4.40 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Floriculture | 806, Meghdoot, New Delhi Delhi 110019 | hindustanagrigenetics@gmail.com http://www.hindustanagrigenetics.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pranav Kapur | Chairman |
| Mr. Pritam Kapur | Managing Director |
| Ms. Chandni Kapur | Director & CFO |
| Ms. Mannu Kohli | Independent Director |
| Mr. Sunny Srivastava | Independent Director |
| Mr. Naren Parsai | Independent Director |